Laparoscopic ovarian drilling in clomiphene citrate resistant polycystic ovarian syndrome patients

M. Sridhar, Chillamherla Susmitha


Background: Polycystic ovarian disease (PCOD) or polycystic ovarian syndrome (PCOS) is a common endocrine disorder which commonly affects women in their reproductive age, often leading to anovulatory infertility. There has been a resurgence of surgical intervention with the advent of ovarian drilling. This study was performed to assess the surgical management for patients with PCOS resistant to hormonal therapy.

Methods: A thorough history and demographic details were taken from all the patients. A detailed clinical examination, along with transvaginal sonography was done. Laparoscopic ovarian drilling was performed on the patients under general anesthesia.

Results: Most of the women were in the 3rd decade of their life and majority of the women had attained menarche at 13 years. The chief complaint of the patients was irregular periods experienced by 80%. 44.4% of the patents had normal BMI, while 31.5% were underweight. Most of the patients (6.7%) showed no evidence of hyperandrogenism, while 20% had hirsutism, 11% had acne.

Conclusions: Polycystic ovarian syndrome is quite prevalent among the women of reproductive age. The effective treatment for PCOS which are resistant to hormonal therapy is laparoscopic drilling of the ovaries which results in ovarian function.


Clomiphene citrate, Infertility, Laparoscopic ovarian drilling, Polycystic ovarian syndrome

Full Text:



Overbeek A, Lambalk CB. Phenotypic and pharmacogenetic aspects of ovulation induction in WHO II anovulatory women. Gynecol Endocrinol. 2009; 25(4):222-34.

March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod. 2010;25:544-51.

Yildiz BO, Bozdag G, Yapici Z, Esinler I, Yarali H. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Hum Reprod. 2012;27:3067-73.

Speroff L, Fritz MA. Anovulation and the polycystic ovary. In: Speroff L, Fritz MA, editors. Clinical Gynecologic Endocrinology and Infertility. 7th ed. Philadelphia (PA): Lippincott Williams and Wilkins; 2005:470-483.

Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab. 2004;89(6):2745-49.

Wang S, Alvero R. Racial, ethnic differences in physiology and clinical symptoms of polycystic ovary syndrome. Semin Reprod Med. 2013;31(5):365-9.

Balen AH. The pathogenesis of the polycystic ovarian syndrome. Lancet. 1999;354:966-7.

Badawy A, Elnashar A. Treatment option for polycystic ovary syndrome. Int J Wom Health. 2011;3:25-35.

Balen AH. Conway GS. Kalsas G. Techatraisak K, Manning PJ, West C. Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Hum Reprod 1995;10:2705-12

Donesky BW, Adashi EY. Surgically induced ovulation in polycystic ovarian syndrome: wedge resection revisited in the age of laparoscopy. Fertil Steril. 1995;63:439-63.

Stein JF, Leventhal ML. Amenorrhoea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 1935;29:181-91.

Mitwally MF, Casper RF. Aromatase inhibitors for the treatment of infertility. Expert Opinion on Investigational Drugs. 2003;12:353-71.

Diamanti-Kandarakis E, Koulli CR, Bergiele AT. A survey of the polycystic ovarian syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab. 1999;84:4006-11.

Bhuvanashree N, Gupta S, Anitha M, Venkatrao E. Polycystic ovarian syndrome: Prevalence and its correlates among adolescent girls. Ann Trop Med Public Health. 2013;6:632-6.

Singh NM, Kamat D, Patel P, Tup NB. Demographic profile, prevalence and treatment modalities received by patients with Polycystic ovarian syndrome: a descriptive study from a rural tertiary care hospital. Nat J Med Dent Res. 2017;5(2):112-7.

Ramanand SJ, Ghongane BB, Ramanand JB, Patwardhan MH, Ghanghas RR, Jain SS. Clinical characteristics of Polycystic ovarian syndrome in Indian women. Ind J Endocrinol Metab. 201;17(1):138-45.

Dunaif A. Insulin resistance and the polycystic ovarian syndrome: mechanism and implications for pathogenesis. Endocrine Rev. 1997;18(6):774-800.

Amer SAK, Li TC, Ledger WL. Ovulation induction using laparoscopic ovarian drilling in women with polycystic ovarian syndrome: predictors of success. Hum Reprod. 2004;19(8):1719-24.

Armar NA, Lachelin GCL. Laparoscopic ovarian diathermy: an effective treatment for anti-estrogen resistant anovulatory infertility in women with polycystic ovaries. Br J Obstet Gynecol. 1993;100:161-4.

Balen AH, Tan SL, Jacobs HS. Hypersecretion of luteinizing hormone: a significant cause of subfertility and miscarria. Br J Obstet Gynecol. 1993;100:1082-9.

Hayashi H, Ezaki K, Endo H, Urashima M. Preoperative luteinizing hormone levels predict the ovulatory response to laparoscopic drilling in patients with clomiphene resistant polycystic ovarian syndrome. Gynecol Endocrinol. 2005;21(6):307-11.

Ott J, Wirth S, Npresent IK, Kurz C, Mayerhofer K, Huber JC, et al. Luteinizing hormone and androstendione are independent predictors of ovulation after laparoscopic ovarian drilling: a retrospective cohort study. Repro Biol Endocrinol. 2009;7:153.

Kong GWS, Cheung LP, Lok IH. Effects of laparoscopic ovarian drilling in treain infertile anovulatory polycystic ovarian syndrome patients with and without metabolic syndrome. Hongkong Med J. 2011;17(1):5-10.